Work disability in inflammatory bowel disease

Slides:

Advertisements

Similar presentations

Inflammatory Bowel Disease: Overview

Advertisements

Is there a link between inflammatory bowel disease and the metabolic syndrome? Hester Franks Academic F2 Supervisors Professors Hawkey and Macdonald.

Baumgart, D C The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis Dtsch Arztebl Int 2009; 106(8): ; DOI: /arztebl

R3. 최태웅 / Pf. 김효종 Alimentary Pharmacology & Therapeutics 19 FEB 2016 DOI: /apt.13547

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States Michael D. Kappelman, Sheryl L. Rifas–Shiman,

Clinical Gastroenterology and Hepatology

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008 Peter Laszlo Lakatos,

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977��2008 Peter Laszlo Lakatos, Gyula David, Tunde Pandur,

Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: A comparative analysis using a reverse transcriptase multiplex ligation-dependent.

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

YouTube® and inflammatory bowel disease

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease Marc Girardin, Serge Dionne, Philippe.

Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells Ashok Kumar.

Medical management of inflammatory bowel disease

Health Care and Research

Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study Livia.

Figure 1 (A): The 0-Isp polyp mimicking inflammatory polyp was found at hepatic flexure. The top surface of the polyp was depressed. (B): Hematoxylin stain.

1 Patient enrollment flow chart.

Serum prohepcidin levels in chronic inflammatory bowel diseases

N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard

Mersin University TURKEY

Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim Journal.

Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: A comparative analysis using a reverse transcriptase multiplex ligation-dependent.

Valle García-Sánchez, Eva Iglesias-Flores, Raúl González, Javier P

Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years May-Bente Bengtson, Camilla.

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

Pregnancy in Primary Sclerosing Cholangitis

Reply Gastroenterology

Volume 143, Issue 2, Pages e1 (August 2012)

Volume 147, Issue 4, Pages e7 (October 2014)

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H

Research and Healthcare in Inflammatory Bowel Diseases (1)

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Osteoporosis in inflammatory bowel disease

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Volume 137, Issue 2, Pages (August 2009)

Reply Gastroenterology

Volume 152, Issue 1, Pages (January 2017)

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.

Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms Mariëlle.

Bowel sonography in occlusive Crohn's disease

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

Individual patients’ FCP (μg/g) values (n=119).

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta

Eligibility criteria for inclusion as an expert Delphi panellist

Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome Claudia I. Reinders, Max Herulf, Tryggve Ljung,

Meenakshi Bewtra, Chinyu Su, James D. Lewis

Volume 135, Issue 6, Pages (December 2008)

David S. Fefferman, Richard J. Farrell

Seasonal variation in flares of inflammatory bowel disease

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States Michael D. Kappelman, Sheryl L. Rifas–Shiman,

Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.

Presentation transcript:

Work disability in inflammatory bowel disease 1 Work disability according to the International Classification of Functioning, Disability and Health (ICF).<sup>17</sup> Work disability in inflammatory bowel disease J Crohns Colitis. 2014;8(7):590-597. doi:10.1016/j.crohns.2013.11.019 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation

Work disability in inflammatory bowel disease 2 Study flowchart. Work disability in inflammatory bowel disease J Crohns Colitis. 2014;8(7):590-597. doi:10.1016/j.crohns.2013.11.019 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation

Work disability in inflammatory bowel disease 3 Work disability in patients aged between 18 and 65 years with Crohn's Disease (CD) and ulcerative colitis (UC) compared to the general population in the Netherlands. Work disability in inflammatory bowel disease J Crohns Colitis. 2014;8(7):590-597. doi:10.1016/j.crohns.2013.11.019 J Crohns Colitis | © 2013 European Crohn's and Colitis Organisation